BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Q, Du R, Liu W, Huang G, Dong Z, Li X. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. Front Oncol 2022;12:852383. [PMID: 35392233 DOI: 10.3389/fonc.2022.852383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu WJ, Zhao Y, Chen X, Miao ML, Zhang RQ. Epigenetic modifications in esophageal cancer: An evolving biomarker. Front Genet 2022;13:1087479. [PMID: 36704345 DOI: 10.3389/fgene.2022.1087479] [Reference Citation Analysis]
2 Zhou Y, Jiang R, Jiang Y, Fu Y, Manafhan Y, Zhu J, Jia E. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis. Cells 2022;11:2980. [DOI: 10.3390/cells11192980] [Reference Citation Analysis]
3 Wang B, Li M, Su A, Gao Y, Shi Y, Li C, Liu W, Su L, Li W, Ma Y, Amantini C. Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma. Analytical Cellular Pathology 2022;2022:1-16. [DOI: 10.1155/2022/9303081] [Reference Citation Analysis]